Top Markets
Coin of the day
Bioptik Technology Incorporation Bioptik Technology Incorporation

Bioptik Technology Incorporation

4161
Clasificación en acciones #26082
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Precio por acción
$0.72978769
Capitalización bursátil
$43.65M
Cambio (1 día)
1.10%
Cambio (1 año)
-17.81%
País
TW
Comercio Bioptik Technology Incorporation (4161)

Categoría

Ratio P/B de Bioptik Technology Incorporation (4161)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Bioptik Technology Incorporation, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Bioptik Technology Incorporation desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
- -
DE